CTCs for High Grade Glioma
| Status: | Recruiting |
|---|---|
| Conditions: | Brain Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | April 2013 |
| Contact: | Robert Lustig, MD |
| Email: | PennCancerTrials@emergingmed.com |
| Phone: | 855-216-0098 |
Circulating Tumor Markers for High Grade Glioma
The purpose of this study is to identify and quantify circulating tumor markers, which are
associated with the presence of tumors. The current imaging available does not allow
specificity of tumor size as it relates to pseudoprogression (a temporary enlargement or
"swelling" of the tumor after treatment before it shrinks). Our hope is that CTCs will
provide a more accurate description of tumor state for high grade glioma patients.
associated with the presence of tumors. The current imaging available does not allow
specificity of tumor size as it relates to pseudoprogression (a temporary enlargement or
"swelling" of the tumor after treatment before it shrinks). Our hope is that CTCs will
provide a more accurate description of tumor state for high grade glioma patients.
Inclusion Criteria:
- Patients with biopsy-proven high grade glioma who are undergoing definitive
radiotherapy as a part of their treatment regimen or patients with radiographic
appearance of high grade glioma
- Age 18 or older
- Signed informed consent
Exclusion Criteria:
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Principal Investigator: Robert Lustig, MD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials
